E

Endo

AcquiredPharmaceuticals

Legal name: Endo, Inc. · Corporation

Malvern, PA
$170.6M
Total Raised
1
Form D filings
Mar 2024
First Raise
May 2024
Last Raise

From SEC Form D filings. Amounts are totals sold as reported by the company, in USD.

Acquired · August 2025

An exit, recorded from the public evidence below.

  • Acquisition record· SEC EDGAR· Aug 1, 2025· checked Oct 17, 2026
    SEC 8-K (Item 5.01, change in control of registrant), followed by Form 15-15D deregistrationSource
Last checked Oct 17, 2026

Funding Timeline

Reg D offeringMar 21, 2024
$170.6M raisedOffering size: $170.6M404 investors
Securities: equity
SEC filing File 021-508269

People

Executive officers, directors and promoters named on the company's SEC Form D filings.

A
Andy Pasternak

Director

Listed May 2024Form D
B
Blaise Coleman

Director · Executive Officer

Listed Mar 2024 – May 2024Form D
F
Frank Raciti

Executive Officer

Listed Mar 2024 – May 2024Form D
M
Marc Yoskowitz

Director

Listed May 2024Form D
M
Mark Bradley

Director · Executive Officer

Listed Mar 2024 – May 2024Form D
M
Matthew Maletta

Director · Executive Officer

Listed Mar 2024 – May 2024Form D
P
Patrick Barry

Executive Officer

Listed Mar 2024 – May 2024Form D
P
Paul Efron

Director

Listed May 2024Form D
P
Paul Herendeen

Director

Listed May 2024Form D
S
Scott Hirsch

Director

Listed May 2024Form D
S
Sophia Langlois

Director

Listed May 2024Form D
B
Brian Morrissey

Executive Officer

Listed Mar 2024Form D

Sources

  • SEC Form D
  • SEC CIK2008861